KYinno
About:
KYinno is a drug development company that is dedicated to oncology drug development with a focus on immune treatments against cancer.
Website: https://www.kyinno.com/
Twitter/X: kyinno_com
Top Investors: Matrix Partners China, BioVenture, Grains Valley Venture Capital, Sunland Capital, Hanne Capital
Description:
KYinno is a drug development company that is dedicated to oncology drug development with a focus on immune treatments against cancer.
Total Funding Amount:
163M CNY
Headquarters Location:
Beijing, Beijing, China
Founded Date:
2017-03-03
Contact Email:
hr(AT)kyinno.cn
Founders:
Jinying Ning
Number of Employees:
51-100
Last Funding Date:
2021-11-29
IPO Status:
Private
Industries:
© 2025 bioDAO.ai